Clinical Trial Update: Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating zoledronic acid to prevent osteoporosis in patients undergoing donor stem cell transplantation. The study included patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndromes
• Osteoporosis
• Ovarian Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: University of Minnesota | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-10-26